| 2018-03-08 | Cohen Jon R | SVP & Group Exec. Diag. Sol. | Sale+OE | 65,632 | $104.23 | $6,840,556.05 | -15.3% | → |
| 2018-03-05 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4,128 | $101.00 | $416,928.00 | -9.4% | → |
| 2018-03-05 | Davis J. E. | EVP, General Diagnostics | Sell | 5,122 | $101.00 | $517,322.00 | -12.1% | → |
| 2018-03-05 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 5,556 | $101.00 | $561,156.00 | -7.6% | → |
| 2018-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,423 | $104.41 | $148,575.74 | -1.7% | → |
| 2018-02-28 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 1,820 | $104.38 | $189,971.08 | -1.3% | → |
| 2018-02-28 | Davis J. E. | EVP, General Diagnostics | Sell | 1,798 | $104.42 | $187,748.52 | -2.4% | → |
| 2018-02-26 | Klug Robert A | VP, Corporate Controller | Sell | 1,157 | $103.66 | $119,932.31 | -22.9% | → |
| 2018-02-26 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 397 | $102.74 | $40,787.78 | -0.6% | → |
| 2018-02-26 | Davis J. E. | EVP, General Diagnostics | Sell | 494 | $102.74 | $50,753.56 | -1.2% | → |
| 2018-01-29 | RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Sale+OE | 106,840 | $107.00 | $11,431,880.00 | -39.1% | → |
| 2018-01-24 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sale+OE | 21,294 | $104.00 | $2,214,576.00 | -23.5% | → |
| 2018-01-02 | Davis J. E. | EVP, General Diagnostics | Sale+OE | 63,880 | $98.68 | $6,303,359.00 | -62.7% | → |
| 2017-09-12 | RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Sale+OE | 59,235 | $108.16 | $6,406,845.35 | -15.1% | → |
| 2017-09-11 | STANZIONE DANIEL | - | Sale+OE | 40,900 | $108.07 | $4,419,940.30 | -54.1% | → |
| 2017-09-05 | STANZIONE DANIEL | - | Sale+OE | 3,803 | $108.01 | $410,762.03 | -9.9% | → |
| 2017-09-05 | RUSCKOWSKI STEPHEN H | Chairman, President and CEO | Sale+OE | 2,525 | $108.03 | $272,768.18 | -1.5% | → |
| 2017-08-04 | LEIDEN JEFFREY M | - | Sell | 296 | $106.66 | $31,571.06 | -4.7% | → |
| 2017-07-27 | LEIDEN JEFFREY M | - | Sell | 1,304 | $108.73 | $141,782.62 | -17.2% | → |
| 2017-06-19 | Cohen Jon R | SVP & Group Exec. Diag. Sol. | Sale+OE | 106,900 | $107.55 | $11,497,134.22 | -12.4% | → |
| 2017-06-19 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sale+OE | 59,762 | $107.55 | $6,427,117.91 | -10.1% | → |
| 2017-04-24 | BRITELL JENNE K | - | Sale+OE | 6,111 | $104.03 | $635,727.33 | -23.5% | → |
| 2017-04-20 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale+OE | 29,513 | $100.00 | $2,951,300.00 | -26.8% | → |
| 2017-03-16 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sale+OE | 13,987 | $100.00 | $1,398,700.00 | -25.8% | → |
| 2017-03-03 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4,478 | $98.29 | $440,142.62 | -10.0% | → |
| 2017-03-03 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 7,162 | $98.28 | $703,907.62 | -4.4% | → |
| 2017-03-01 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 470 | $97.77 | $45,951.90 | -1.2% | → |
| 2017-02-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 440 | $97.39 | $42,851.60 | -1.1% | → |
| 2017-02-22 | ZIEGLER JOHN B | - | Sell | 2,000 | $95.51 | $191,016.00 | -10.8% | → |